Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial.
Saved in:
| Title: | Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial. |
|---|---|
| Authors: | Marrazzo JM; Department of Medicine, University of Alabama at Birmingham., Dombrowski JC; Department of Medicine, University of Washington, Seattle., Wierzbicki MR; Emmes Corporation, Rockville, Maryland., Perlowski C; FHI360, Durham, North Carolina., Pontius A; Department of Medicine, University of Alabama at Birmingham., Dithmer D; Department of Medicine, University of Washington, Seattle., Schwebke J; Department of Medicine, University of Alabama at Birmingham. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2019 Feb 15; Vol. 68 (5), pp. 803-809. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6591 |
|---|---|
| DOI: | 10.1093/cid/ciy554 |
